Atlas Trials

Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy

Clinical trial NCT03262363 · UNKNOWN

Trial details

NCT number
NCT03262363
Sponsor
Unidad de Investigacion Medica en Enfermedades Renales
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Chronic Kidney DiseasesDiabetes Mellitus, Type 2Polymorphism
Start date
2018-08-01
Primary completion
2019-02-28
Enrollment
176

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.